BeOne Medicines Ltd (ONC) Stock Price, Quote, News & History

ONCNASDAQ
$347.98
-5.85-1.65%
Last update: Sep 15, 3:31 PM

BeOne Medicines (ONC) Stock Price, Quote, News & History | Benzinga

40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
1.48B
Investing Cash Flow (TTM)
-182.47M
Financing Cash Flow (TTM)
1.12B
Free Cash Flow (TTM)
1.31B
Capital Expenditure (TTM)
-175.08M
Net Change in Cash (TTM)
2.42B

Analyst Trends and Forecast

1
Jun
5
Jul
5
Aug
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$37.23B
PE Ratio (TTM)
63.30
PE Ratio (FWD)
34.13
PEG Ratio (TTM)
0.75
PS Ratio (TTM)
6.66
PB Ratio (TTM)
7.74
Earnings Yield % (TTM)
1.58%
Earnings Yield % (FWD)
2.93%
EV / EBITDA (TTM)
32.69
Price / EBITDA (TTM)
35.86
Price / Free Cash Flow (TTM)
31.20
Book Value / Share
$45.74

Company Debt

Total Debt
$1.07B
LT Debt
$882.16M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$43.57M
Total Cash
$5.10B
Debt to Equity
0.22
Issuance of Debt (TTM)
$807.01M
Repayment of Debt (TTM)
-$812.57M

Key Statistics

Open
$353.55
Close
-
Volume / Avg.
145.15K / 372.23K
Day Range
$346.18 - $354.50
52 Wk Range
253.95 - 385.22
Market Cap
$39.36B
P/E Ratio
63.30
Dividend Yield
-
Exchange
NASDAQ
RSI
46
Short Interest
1.77%
Days to Cover
4.16

About

Sector
Health Care
Industry
Biotechnology
Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of non-Hodgkin l...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy BeOne Medicines (ONC) stock?

A

You can purchase shares of BeOne Medicines (NASDAQ:ONC) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BeOne Medicines (ONC) competitors?

Q

What is the forecast, or price target, for BeOne Medicines (ONC) stock?

A

BeOne Medicines has a consensus price target of $385.85.

Q

What is the current price for BeOne Medicines (ONC)?

A

The stock price for BeOne Medicines (NASDAQ: ONC) is $347.975 last updated September 15, 2026 at 3:31 PM EDT.

Q

Does BeOne Medicines (ONC) pay a dividend?

A

There are no upcoming dividends for BeOne Medicines.

Q

When is BeOne Medicines (NASDAQ:ONC) reporting earnings?

A

BeOne Medicines does not have any upcoming earnings scheduled.

Q

Is BeOne Medicines (ONC) going to split?

A

There is no upcoming split for BeOne Medicines.

Q

What sector and industry does BeOne Medicines (ONC) operate in?

A

BeOne Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.